Hospital General De Segovia

Segovia 14 trials 5 recruiting

14 Registered trials

5 Currently recruiting

Organisation

Hospital General De Segovia

Location

Segovia, Spain

Identifier

ORG-100043596

Address

Calle De Luis Erik Claveria, 47002, Spain

Departments

Allergy
Endocrinologia y Nutrición
Endocrinology
Endocrinology and nutrition
Endocrinology and Nutrition Unit
Hematología
Hematology
N/A
Oncology
Pneumology

Clinical trials at this site (14)

Search interface

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
Clinical trial to asses the efficacy and safety of a vaccine for grasses and cupressaceae allergy Recruiting

2024-514524-16-00 Aetiological treatment of moderate-severe intermitent o 5 2021-05-11
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
Extended VRD plus Early Rescue vs Isatuximab-VRD vs Isatuximab-VIberdomide-D for NDMM patients who are candidates for ASCT Ended

2024-517008-12-00 Newly-diagnosed multiple myeloma (NDMM) 5 2022-10-14
Study to evaluate the efficacy of 3 different treatments, followed by maintenance treatment, in older adult patients, between 65 and 80 year… Ended

2024-516905-22-00 Multiple myeloma 5 2018-10-22
Study to evaluate the effectiveness of a combination of 3 treatments, followed by transplantation of their own blood cell progenitor cells f… Ended

2024-516908-42-00 Smoldering multiple myeloma with high risk of progressi 4 2015-06-15
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight… Ended

2022-502678-18-00 Type 2 diabetes 5 2023-11-07
The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the tr… Ended

2022-500449-26-00 Type 2 diabetes mellitus (T2DM) 6 2023-08-03
A Study of Daily Oral Orforglipron Compared with Insulin Glargine in Participants with Type 2 Diabetes and Obesity or Overweight at Increase… Ended

2022-502833-25-00 Obesity 5 2023-08-02
A 12-month, randomized, single-blind, placebo-controlled exposure-response study of TCD601 (siplizumab) in new onset type 1 diabetes patient… Ended

2023-506837-31-00 New onset type I diabetes 4 2023-01-27